Indefinite Delivery Contract 36C25022D0067

Award Date 8/26/22
Last Date to Order 8/24/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) 36C25024D0118 was awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 10, to Miravista Diagnostics LLC, a for-profit limited liability company that manufactures goods and provides clinical laboratory testing services. The contract, valued at $238,035, is for reference laboratory fungal testing services to support VA healthcare programs in Michigan and Indiana. It is a single-award IDC with a...
This federal contract IDV award is for a Delivery Order contract between the Department of Veterans Affairs (VA) and Miravista Diagnostics LLC, a for-profit limited liability company specializing in clinical laboratory testing services, particularly fungal and microbiology diagnostic testing. The contract, valued at $462,375.00, was awarded on May 20, 2025, with a performance period through May 19, 2030. Miravista Diagnostics LLC has previously been awarded several Indefinite Delivery...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a single award Indefinite Delivery Contract to Biomerieux Inc. with a potential value of $7.4 million to provide identification, antimicrobial susceptibility testing, and matrix-assisted laser desorption/ionization clinical proteomics technology solutions. The original solicitation posted on January 18, 2023 sought these laboratory diagnostic testing equipment and services with a...
The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Biomerieux Inc. for VISN 8 Molecular Pathogen Detection. The contract, valued at $31,825,821.12, has an ultimate completion date of January 12, 2030, and was awarded on January 13, 2025. Under this IDC, Biomerieux Inc., through its Biomerieux, Inc. Division, will provide in-vitro diagnostic test panels, equipment, and related services to support molecular pathogen detection capabilities at...
The U.S. Department of Veterans Affairs (VA) has awarded a single-award, indefinite delivery contract to Biomerieux Inc., a global leader in in vitro diagnostics, to provide bacterial identification and antibiotic susceptibility testing services to the VA's Veterans Integrated Service Network 2 (VISN 2). The contract, valued at a ceiling of $2,366,377.51, has an ultimate completion date of March 31, 2026 and does not utilize any set-aside designations. Under this IDC, Biomerieux Inc., through...
The U.S. Department of Veterans Affairs (VA) has awarded multiple federal contract Indefinite Delivery Vehicles (IDVs) to Mdxhealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services. These IDVs, primarily Blanket Purchase Agreements (BPAs) issued under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), enable the VA to efficiently procure a range of cancer screening and diagnostic testing services from Mdxhealth to...
The U.S. Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to The Binding Site, Inc., a medical diagnostics company, to provide specialized laboratory equipment, reagents, and testing services for clinical pathology and diagnostic programs at VA medical facilities. The $931,034.03 IDC has an ordering period through September 30, 2026 and includes multiple delivery orders for "Special Proteins Analyzer Cost Per Test" services valued at...
The Department of Veterans Affairs (VA), Veterans Health Administration, Network Contracting Office 17, has awarded a firm-fixed-price Indefinite Delivery Contract (IDC) to Karius, Inc., a life sciences company specializing in diagnostic services for infectious diseases. The IDC, valued at $600,000 and effective through July 31, 2027, allows the VA to purchase next-generation sequencing (NGS) tests from Karius at $2,000 per test. Karius has been identified as the sole responsible source...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a single-award Indefinite Delivery Contract (IDC) to Diasorin Molecular LLC, a foreign-owned medical diagnostics manufacturer, to provide COVID-19 tests, analyzers, and related laboratory equipment. The $10 million IDC, issued through VA's Veterans Integrated Service Network (VISN) 23, has an ultimate completion date of September 30, 2026. Under this IDC, Diasorin Molecular has received numerous firm-fixed price...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA), Network Contracting Office (NCO) 21, to Diacarta, Inc. for reference laboratory testing services to aid in the diagnosis of VEXAS Syndrome. The contract has a total ceiling value of $200,000 and a period of performance from October 1, 2024 to September 30, 2029. The key services under this contract include specimen pickup, testing for somatic mutations of the UBA1 gene, reporting, and consultation....
  • 36C25022D0067
    Indefinite Delivery Contract
  • 3
    Federal Contract Awards

The Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Miravista Diagnostics LLC, a for-profit limited liability company, for specialized reference laboratory testing services. The single-award IDC, valued at up to $240,445, was issued by the VA's Veterans Integrated Service Network 10 (VISN 10) to provide fungal and microbiology testing to support healthcare programs in Michigan and Indiana. Under this IDC, Miravista Diagnostics has received multiple delivery orders, including a $64,778.95 order for reference lab testing, a $55,185.50 order for reference lab testing, and a $50,607 order for specialized laboratory services. The contract does not have a set-aside designation. Miravista Diagnostics is known for its expertise in fungal diagnostics and has developed novel testing methods for endemic mycoses. The company has also received federal grants, such as a $999,212 Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) to create a diagnostic tool for coccidioidomycosis (Valley Fever).

The original contract opportunity, issued as a pre-solicitation by the VA's Ann Arbor Healthcare System, sought a firm-fixed-price contract for specialized reference laboratory services. The government intended to negotiate a sole-source award with Miravista Diagnostics due to the company's patents on the required testing methods. The contract period of performance is one year with four one-year option periods, and the work is to be performed in Ann Arbor, Michigan.

Generated 9/7/24, 9:51 AM